The price of Rubius Therapeutics Inc. (NASDAQ: RUBY) closed at $0.26 in the last session, up 3.44% from day before closing price of $0.25. In other words, the price has increased by $+0.0086 from its previous closing price. On the day, 1111995 shares were traded. RUBY stock price reached its highest trading level at $0.2695 during the session, while it also had its lowest trading level at $0.2401.
We take a closer look at RUBY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.40 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 2.10.
Upgrades & Downgrades
SVB Leerink Downgraded its Outperform to Mkt Perform on March 13, 2020, whereas the target price for the stock was revised from $19 to $4.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 10 when Appelhans Dannielle sold 5,737 shares for $0.80 per share. The transaction valued at 4,590 led to the insider holds 6,763 shares of the business.
Epstein David R bought 30,000 shares of RUBY for $43,329 on Apr 21. The Director now owns 4,720,012 shares after completing the transaction at $1.44 per share. On Feb 01, another insider, CAGNONI PABLO J, who serves as the CEO and President of the company, sold 6,730 shares for $6.57 each. As a result, the insider received 44,236 and left with 35,520 shares of the company.
Stock Price History:
Over the past 52 weeks, RUBY has reached a high of $7.76, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 0.2081, while the 200-Day Moving Average is calculated to be 0.7756.
According to the various share statistics, RUBY traded on average about 1.23M shares per day over the past 3-months and 2.08M shares per day over the past 10 days. A total of 90.36M shares are outstanding, with a floating share count of 84.40M. Insiders hold about 5.51% of the company’s shares, while institutions hold 76.60% stake in the company. Shares short for RUBY as of Oct 13, 2022 were 2.67M with a Short Ratio of 2.04M, compared to 2.51M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.95% and a Short% of Float of 7.99%.
The company has 3 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.44, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.19 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.56 and -$1.85 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$0.7, with 3 analysts recommending between -$0.32 and -$0.98.